Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ramat Gan
Clinical trial register · Israel

Clinical Trials in Ramat Gan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2438 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2438
Studies in scope
all four open statuses
1243
Recruiting now
open to new participants
461
Lead sponsors
across recruiting studies
Top sites
Haifa 52 Ramat Gan 50 Tel Aviv 47 Jerusalem 46 Petah Tikva 37
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC86 AbbVie67 Janssen Research & Development, LLC50 AstraZeneca43 Sheba Medical Center30 Clear sponsor filter
Site location
Haifa52 Ramat Gan50 Tel Aviv47 Jerusalem46 Petah Tikva37
All 27 locations
Target enrolment
to

Trials with a site in Ramat Gan

50 of 2438 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2026-09-09
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Ashdod, Haifa, Petah Tikva, Ramat Gan, Tel Aviv
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Ashdod, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Ashdod, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan
2026-05-22
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Beersheba, Haifa, Jerusalem, Ramat Gan, Ramat Poriya, Tel Aviv
2026-02-04
Recruiting
Janssen Research & Development, LLC
Observational
380
Petah Tikva, Ramat Gan, Tel Aviv
2025-12-03
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Afula, Ashdod, Be’er Ya‘aqov, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Afula, Ashdod, Be’er Ya‘aqov, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan
2025-10-01
Recruiting
Janssen Research & Development, LLC
Phase 3
220
Haifa, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
2025-09-10
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Beer Yaakov, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2025-06-04
Recruiting
Janssen Research & Development, LLC
Phase 3
50
Ramat Gan
2025-02-10
Recruiting
Janssen Research & Development, LLC
Phase 2
480
Beersheba, Haifa, Kfar Saba, Ramat Gan
2024-12-16
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Beer Yaakov, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2024-12-12
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Ashkelon, Haifa, Har Poriyya, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
2024-12-04
Recruiting
Janssen Research & Development, LLC
Phase 1
276
Haifa, Jerusalem, Ramat Gan, Tel Aviv
2024-12-04
Recruiting
Janssen Research & Development, LLC
Phase 3
39
Ramat Gan
2024-11-11
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Beer Yaakov, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2024-10-18
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Haifa, Jerusalem, Ramat Gan, Tel Aviv
2024-06-07
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Haifa, Jerusalem, Ramat Gan, Safed, Tel Aviv
2024-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Be’er Ya‘aqov, Haifa, Petah Tikva, Ramat Gan, Tel Aviv
2024-01-22
Recruiting
Janssen Research & Development, LLC
Phase 1
300
Haifa, Jerusalem, Ramat Gan, Tel Aviv
2023-12-20
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Jerusalem, Petah Tikva, Ramat Gan
2023-12-20
Active, closed
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
NCT05784441Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC
Phase 1
21
Jerusalem, Ramat Gan
2023-11-06
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Hadera, Haifa, Petah Tikva, Ramat Gan, Tel Aviv
2023-03-29
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Beersheba, Haifa, Jerusalem, Naharya, Petah Tikva, Ramat Gan, Safed, Tel Aviv
2023-02-15
Recruiting
Janssen Research & Development, LLC
Phase 2
520
Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2022-11-11
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Beersheba, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2022-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Afula, Be’er Ya‘aqov, Hadera, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan
2022-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Afula, Haifa, Holon, Jerusalem, Nahariya, Ramat Gan
2022-09-13
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2022-08-05
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Afula, Beersheba, Ramat Gan, Rehovot, Tzrifin
2022-01-19
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Beersheba, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
2021-11-17
Active, closed
A Long-term Extension Study of Ustekinumab in Pediatric Participants
NCT05092269Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic
DrugUstekinumab
Janssen Research & Development, LLC
Phase 3
159
Beer Yaakov, Jerusalem, Ramat Gan
2021-10-18
Active, closed
Janssen Research & Development, LLC
Phase 4
411
Haifa, Holon, Kfar Saba, Ramat Gan
2021-08-30
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Jerusalem, Ramat Gan, Tel Aviv
2021-08-19
Active, closed
Janssen Research & Development, LLC
Phase 3
1,054
Ashkelon, Haifa, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
2021-06-17
Recruiting
Janssen Research & Development, LLC
Phase 1/2
420
Haifa, Jerusalem, Ramat Gan, Tel Aviv
2021-05-19
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Haifa, Jerusalem, Ramat Gan, Tel Aviv
2021-02-01
Active, closed
Janssen Research & Development, LLC
Phase 1/2
228
Jerusalem, Ramat Gan, Tel Aviv
2020-12-15
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Afula, Beersheba, Haifa, Jerusalem, Petach Tikvah, Ramat Gan, Tel Aviv
2020-09-23
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Jerusalem, Ramat Gan, Tel Aviv
2020-06-12
Active, closed
Janssen Research & Development, LLC
Phase 2
208
Ramat Gan, Tel Aviv
2019-11-07
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Beer Yaakov, Haifa, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
2019-06-11
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Beer Yaakov, Haifa, Petah Tikva, Ramat Gan
2019-01-25
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Rishon LeZiyyon, Tel Aviv
2018-10-29
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Haifa, Jerusalem, Nahariya, Ramat Gan, Tel Aviv
2018-04-17
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Afula, Ashkelon, Bear Sheva, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2018-04-13
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Beer Yaakov, Beersheba, Haifa, Petah Tikva, Ramat Gan
2018-03-02
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Afula, Hadera, Haifa, Petah Tikva, Ramat Gan, Tel Aviv
2013-09-09
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-israel/city/ramat-gan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,438 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in Ramat Gan that also match the filters currently applied.

How many clinical trials are recruiting in Ramat Gan?

23 of the 50 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 27 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ramat Gan), 50 studies
PhaseStudiesRecruitingShare
Phase 3351570%
Phase 25310%
Phase 1428%
Phase 1/2214%
Phase 2/3214%
Observational112%
Phase 4102%

Most active sponsors

Lead sponsors with the most studies (Ramat Gan)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC5023
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.